California Public Employees Retirement System lessened its holdings in shares of Halyard Health, Inc. (NYSE:HYH) by 10.2% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 130,745 shares of the medical instruments supplier’s stock after selling 14,900 shares during the period. California Public Employees Retirement System owned 0.28% of Halyard Health worth $5,136,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also added to or reduced their stakes in HYH. Patten Group Inc. increased its stake in shares of Halyard Health by 0.4% during the first quarter. Patten Group Inc. now owns 19,629 shares of the medical instruments supplier’s stock valued at $769,000 after acquiring an additional 75 shares during the period. Amalgamated Bank increased its stake in shares of Halyard Health by 1.2% during the second quarter. Amalgamated Bank now owns 6,655 shares of the medical instruments supplier’s stock valued at $261,000 after acquiring an additional 82 shares during the period. Somerset Trust Co increased its stake in shares of Halyard Health by 0.7% during the second quarter. Somerset Trust Co now owns 12,618 shares of the medical instruments supplier’s stock valued at $495,000 after acquiring an additional 90 shares during the period. Advantus Capital Management Inc increased its stake in shares of Halyard Health by 3.0% during the first quarter. Advantus Capital Management Inc now owns 5,975 shares of the medical instruments supplier’s stock valued at $228,000 after acquiring an additional 175 shares during the period. Finally, Creative Planning increased its stake in shares of Halyard Health by 3.9% during the second quarter. Creative Planning now owns 5,901 shares of the medical instruments supplier’s stock valued at $232,000 after acquiring an additional 222 shares during the period. 91.02% of the stock is currently owned by institutional investors.

COPYRIGHT VIOLATION NOTICE: This piece of content was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece of content on another publication, it was stolen and reposted in violation of US and international trademark and copyright legislation. The correct version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/10/19/halyard-health-inc-hyh-stake-decreased-by-california-public-employees-retirement-system.html.

Halyard Health, Inc. (NYSE:HYH) opened at 43.51 on Thursday. The company’s 50 day moving average is $45.30 and its 200-day moving average is $40.65. Halyard Health, Inc. has a 1-year low of $31.59 and a 1-year high of $46.63. The firm has a market cap of $2.03 billion, a price-to-earnings ratio of 41.84 and a beta of 1.75.

Halyard Health (NYSE:HYH) last announced its earnings results on Wednesday, August 2nd. The medical instruments supplier reported $0.51 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.37 by $0.14. Halyard Health had a net margin of 3.06% and a return on equity of 8.29%. The company had revenue of $399.20 million for the quarter, compared to analyst estimates of $399.16 million. During the same period in the prior year, the business earned $0.45 earnings per share. Halyard Health’s quarterly revenue was down .2% on a year-over-year basis. On average, analysts predict that Halyard Health, Inc. will post $1.95 EPS for the current fiscal year.

A number of research analysts recently commented on HYH shares. BidaskClub upgraded shares of Halyard Health from a “hold” rating to a “buy” rating in a research note on Saturday, August 19th. Deutsche Bank AG raised their price objective on shares of Halyard Health from $35.00 to $42.00 and gave the company a “buy” rating in a research note on Thursday, August 3rd. Zacks Investment Research lowered shares of Halyard Health from a “buy” rating to a “sell” rating in a research note on Wednesday, October 4th. Stifel Nicolaus reiterated a “buy” rating and set a $45.00 price objective on shares of Halyard Health in a research note on Thursday, September 21st. Finally, KeyCorp reiterated a “hold” rating on shares of Halyard Health in a research note on Tuesday. One analyst has rated the stock with a sell rating, two have issued a hold rating and four have assigned a buy rating to the stock. Halyard Health currently has an average rating of “Hold” and a consensus target price of $42.25.

About Halyard Health

Halyard Health, Inc is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare supplies and solutions that target the prevention of healthcare-associated infections.

Institutional Ownership by Quarter for Halyard Health (NYSE:HYH)

Receive News & Stock Ratings for Halyard Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halyard Health Inc. and related stocks with our FREE daily email newsletter.